Description

LINAGLIP-M is a combination medication available in three formulations:

LINAGLIP-M with Linagliptin 2.5 mg + Metformin 500 mg Tablets

LINAGLIP-M with Linagliptin 2.5 mg + Metformin 850 mg Tablets

LINAGLIP-M with Linagliptin 2.5 mg + Metformin 1000 mg Tablets

The combination includes the active ingredients Linagliptin, a dipeptidyl peptidase-4 (DPP-4) inhibitor, and Metformin, a biguanide.
The medication is manufactured by Asian Pharmaceuticals.
LINAGLIP-M is commonly prescribed for individuals with type 2 diabetes to improve glycemic control through dual mechanisms: by increasing insulin sensitivity with Metformin and by inhibiting the breakdown of incretin hormones with Linagliptin.

About Supplier

Asia Pharma Link committed to bridging healthcare gaps and plays a vital role in distributing medical and surgical items to various locations across Nepal. With a focus on ensuring widespread access to quality healthcare, the company serves as a crucial link in the pharmaceutical supply chain. Whether catering to healthcare professionals or meeting the needs of consumers, Asia Pharma Link takes pride in its role as a reliable source of essential medicines. With a broad distribution network, the company extends its reach to different regions of Nepal, contributing significantly to the nation's healthcare landscape.